Prevalence of HIV and hepatitis C markers among a cadaver population in Milan

Journal of Clinical Pathology

Volumn 52, Issue 4, 1999, Pages 267-270

  Cattaneo, C ^a   Nuttall, P A ^b   Molendini, L O ^a   Pellegrinelli, M ^a   Grandi, M ^a   Sokol, R J ^b  

^a Institute of Legal Medicine   (Italy)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cadaver; Enzyme linked immunosorbent assay; Forensic medicine; Hepatitis C; HIV

Indexed keywords

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CADAVER; CAUSE OF DEATH; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0032962136     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.4.267     Document Type: Article

References (19)

1. 1 Metters J, chairman. Unlinked anonymous HIV prevalence monitoring programme England and Wales. Report from the unlinked anonymous surveys steering group. London: Department of Health, 1996.
2. 2 Dianzani F, Ippolito G, Morano M. AIDS 1998: il contributo Italiano. Padova: PICCIN, 1998.
3. 3 Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-5.
4. 4 Goldberg D, Cameron S, McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health 1998;1:95-7.
5. 5 Ramsay ME, Balogun MA, Collins M, et al. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health 1998;1:89-94.
6. 6 Karhunen PJ, Brummer-Korvenkontio H, Laaksonen H, et al. Surveillance of human immunodeficiency virus (HIV) antibodies in medicolegal autopsy in Finland - monitoring of early changes in HIV-seropositivity among risk groups and average population. J Forensic Sci 1992;37:1261-8.
7. 7 Cattaneo C, Nuttall P, Molendini I, et al. HIV testing of cadaveric blood using screening techniques devised for transfusion practice. Transfus Med 1996;6(suppl 2):37.
8. 8 Cattaneo C, Nuttall P, Sokol RJ. Detection of HIV, hepatitis B and hepatitis C markers in discarded syringes and blood-stains. Sci Justice 1996;36:271-4.
9. 9 Cattaneo C, Molendini LO, Nuttall PA, et al. HIV, HCV and HBsAg testing of cadavers: the use of blood transfusion techniques in forensic practice. Transfus Med 1997;7(suppl 1):45.
10. 10 Lockemann U, Schulz-Schaeffer W, Wischhusen F, et al. HIV-1 prevalence in fatalities from Hamburg, Germany. Int J Legal Med 1993;106:11-13.
11. 11 Lockemann U, Püschel K. HIV-1 prevalence among drug deaths - a multi-center study. Forensic Sci Int 1993;62:89-93.
12. 12 Kringsholm B, Theilade P, Geertinger P. The occurrence of HIV antibodies in drug addicts autopsied at the University Institute of Forensic Medicine in Copenhagen in 1987. Forensic Sci Int 1989;41:281-4.
13. 13 Kringsholm B, Theilade P. Prevalence of HIV-1 antibodies in drug addicts autopsied at the University Institute of Forensic Pathology in Copenhagen 1988-1991. Forensic Sci Int 1992;55:83-92.
14. 14 Paterson SC, Vanezis P, Claydon SM. Drug addict deaths in North and West London and prevalence of HIV and hepatitis B infection. Sci Justice 1996;36:85-8.
15. 15 Püschel K, Lockemann U, Schneider V, et al. HIV-1-prevalence among drug deaths in major cities of central and northern Europe. Forensic Sci Int 1992;57:57-62.
16. 16 Rajs J, Karlsson T, Eklund B, et al. HIV-related deaths outside medical institutions in Stockholm. Forensic Sci Int 1989;41:269-80.
17. 17 Sadler DW, Pounder DJ, Urquhart GED, et al. Prevalence of HIV antibody in forensic cases. BMJ 1992;304:1027-8.
18. 18 Wreghitt TG, Irish N. Transmission of blood-borne viruses after motor-car accidents. Lancet 1998;351:450-1.
19. 19 Gilbart VL, Raeside F, Evans BG, et al. Unusual HIV transmissions through blood contact: analysis of cases reported in the United Kingdom to December 1997. Commun Dis Public Health 1998;1:108-13.